Member Info for Jimzi

You clearly didn't read the post you were replying to.

This RNS has just given the BOD all the marketing material they need for insurance companies [coming from their own industry]. Like the business model and recurring revenue, a thing of beauty.

Appears the wider market have missed the magnitude of the RNS. This is the company maker. Its independent financial confirmation of the company's model and almost certain success - globally.

40% reduction is a jaw dropping cost saving for insurance companies. [billions]

Could be that LSE not posted RNS I suppose.

LND - up 50% on a discounted placing but to international player.

We have a strategic investor TBA and a trading partnership with a global.

Join the dots gents. - with our mcap of £850k!

The whole problem is its all totally illiquid save PDBS which is on the floor at $2.7.

Continual funding here and there does nothing. They need to have some healthy crystallisations for even a modest rise.

Tell me which insurance company is not going to join the party. It is now a must have product. Globally. And there’s no competition.

Think of the enormity of that 40% reduction has on insurers business . Independently verified. Gamechaging info

Why. Everyone apart from our bored 13 trade trader are happy waiting.

Its called investing.

So that explains the large trades last week -sipp transfers

Craig holds a decent amount now

Peeps selling so close to the placing price given yesterdays excellent RNS and interview - but I can't work out the market anymore!! I mean 2 insurers expanding into new states means they love it - the market has accepted it ergo recurring rev model is upon us. Awaiting insurer ££ feedback at the conference with great interest

Confirmation of the trading partnership with the global multinational co for one. The implications of an independent high margin income stream are transformational for a £1m mcap junior.

Bet He1 holders had the same forward looking BOD

Suggest you read the RNS. Strategic investor already lined up for one years funding post AGM .

Looks like the 500k buy took the last remnants of the non sticky placing. Should consolidate from here

"Sounds like an insurer is going to release some information on the commercial benefit of leakbot."

The more I think about it, I'm sure he will RNS the details during the conference - if its good lol. I think he knows though.

Wednesday wasn't it?

Yes, it may be the litmus paper to the re-rate.

Some Peeps moaning about the speed of progress - the interview dispells that imo

He just didn't partake in the placing so his % is down

The over hang is not huge or exist. RSP for 200k is 13.5p - has been for weeks.

As there is little action, it is being controlled by around 500k shares traded in and out. [which has a magnified effect given the low share no. [as can be seen with the 200k quote.]

Succinct summary from Twitter:

Hugely positive news for the company - and for me, it suggests that additional states will be targeted soon enough. The US is the largest of Ondo's target markets; and, owing to the market dynamics (i.e. higher premiums) is the most lucrative. All four of Ondo's US insurance partners have entered into the same commercial arrangement, being all-in recurring monthly subscription of $5 per month, per device.

Rapidly building annual recurring revenue = tremendous value driver.

The opportunity ahead for Ondo is absolutely massive, and management is executing it rollout strategy impressively.

Excellent news and use of placing proceeds 👍